Home / Peptide products / Neoplasm / Octreotide acetate
Filters
Catalog peptides
Synthesis of unnatural amino acids and other blocks
Octreotide acetate
Name
Octreotide acetate
Molecular structural formula
Purity
≥98%
CAS Number
79517-01-4
Formula
C51H70N10O12S2
MW
1079.29
Target
Somatostatin Receptor
Sequence
D-Phe-Cys(1)-Phe-D-Trp-Lys-Thr-Cys(1)-Thr-ol(Disulfide bridge: Cys2-Cys7)
Sequence Shortening
fCFwKTCT-ol(Disulfide bridge: Cys2-Cys7)
InChIKey
DEQANNDTNATYII-OULOTJBUSA-N
Solubility in DMSO
250 mg/mL
Solubility in water
25 mg/mL
References
[1]. Wang M, et al. Pharmacokinetic and pharmacodynamic study of a phospholipid-based phase separation gel for once a month administration of octreotide. J Control Release. 2016 May 28;230:45-56. [2]. Kim S, et al. Treatment of Gastrin-Secreting Tumor With Sustained-Release Octreotide Acetate in a Dog. J Am Anim Hosp Assoc. 2015 Nov-Dec;51(6):407-12.
* All products on our website are for scientific research and cannot be used in human body
Product details
Data download

Octreotide acetate, a long-acting synthetic analog of native somatostatin, inhibits growth hormone, glucagon, and insulin more potently.